Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 12:56 AM
NCT ID:
NCT04684667
Eligibility Criteria:
Inclusion Criteria:
* Children diagnosed with problematic infantile hemangiomas:
A-Large hemangiomas at increased risk of scarring or disfigurement at any site. B-Hemangiomas carrying functional risks near the eyes, nose, natural orifices, limbs, genitalia.
C-Ulcerated infantile hemangiomas. D-Uncomplicated progressive infantile hemangiomas with unpredictable future course.
E-Life-threatening hemangiomas.
* Multiple hemangiomas
Exclusion Criteria:
* Patients older than 1 year of age.
* Patients with heart diseases.
* Patients with history of bronchspasm or wheezing.
* Patients with Hypotension.
* Patients with Hypertension.
* Premature infants with corrected age less than 5 weeks.
* Patients with conditions affecting blood glucose maintenance.
* Patients with liver failure.
* Patients with PHACES syndrome.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
1 Year
Study:
NCT04684667
Study Brief:
Protocol Section:
NCT04684667